During an investor and analyst meeting hosted today in New York, BioLineRx Ltd. (Nasdaq: BLRX) will disclose its multi-year development ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE